FDA approves opioid addiction medication in implant form
The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »
ASHP meets with White House officials on opioid addicition
The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »
Studies on Incyte drug to be presented at ASCO, EHA conferences
Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »
CHMP offers approval recomendation for potential diabetes treatment
The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »
FDA committee recommends diabetes treatment option for approval
Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »
Rising drug prices expected to expand exclusion lists, Tufts expert says
Expanded exclusion lists also could impact pharmacies, patients. Read More »
Zika prevention webinar launched by NACDS Foundation
Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »
McKesson announces ideaShare conference and exhibition program
The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »
NACDS announces 'Train-the-Trainer' national tour
Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »
New MS treatment approved by FDA
Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »
FDA approves TEFLARO for use in pediatric patients
First branded IV antibiotic approved for use with children in more than 10 years. Read More »
CVS Pharmacy collaborates with American Diabetes Association to stop diabetes
CVS Pharmacy becomes the exclusive drugstore for the "Partner in Healthy Living" initiative. Read More »
Allergan and Medicines360 donate birth control devices to CDC Foundation
IUDs and oral contraceptives donated to help prevent pregnancy in areas affected by the zika virus. Read More »
FDA grants accelerated approval for new liver disease therapy
Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »
HSS provides greater transparency about health information technology
Upgraded website, plain language disclosures and frequent updates will help health care providers make informed decisions when purchasing health IT. Read More »
First Benzer Pharmacy franchise opens in Tampa
Kalia partners with Benzer Pharmacy to establish franchise in Tampa, Florida. Read More »
Daiichi Sankyo to discontinue HER3-Lung study
The clinical trial evaluating patritumab as a treatment in non-small cell lung cancer will not proceed to the second part. Read More »
CVS Health receives two CIO distinguished awards
The CIO interactive community recognized CVS Health for excellence and leadership in IT. Read More »
Nominations now being accepted for American Pharmacists Association's annual awards
The American Pharmacists Association's (APhA) annual awards and honors program is set for March 24-27, 2017, and award nominations are being accepted now. Read More »
Pharmacy Podcast Show marks 300th episode
The Pharmacy Podcast Show recently marked a milestone - its 300th episode. Read More »
Alerts Sign-up